LINC01266: A Potential Drug Target and Biomarker (G101927215)

Target Name: LINC01266

NCBI ID: G101927215

LINC01266

Other Name(s): Long intergenic non-protein coding RNA 1266 | long intergenic non-protein coding RNA 1266

LINC01266: A Potential Drug Target and Biomarker

LINC01266 is a non-coding RNA (ncRNA) that has been identified by bioinformatic analysis as belonging to the LINC (Long non-coding RNAs) family. This family of ncRNAs has been shown to play important roles in various biological processes, including gene regulation, tissue development, and embryonic development. LINC01266 has also been shown to be involved in cell survival and has been associated with various diseases, including cancer. Therefore, it is a potential drug target and biomarker that could be targeted by small molecules or other therapeutic agents.

Disease-Related Expression

LINC01266 has been shown to be involved in a variety of diseases, including cancer. For example, studies have shown that LINC01266 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LINC01266 has been shown to be involved in the regulation of cell survival, which is a key factor in cancer progression.

Drug Target Potential

LINC01266 is a potential drug target due to its involvement in cell survival and its expression in various diseases. Small molecules have been shown to be effective in inhibiting LINC01266 function, leading to the potential for these molecules to be used as therapeutic agents. Additionally, LINC01266 has been shown to be a good biomarker for cancer, which could make it an attractive target for diagnostic tools.

Biomarker Potential

LINC01266 has also been shown to be a potential biomarker for cancer. The high expression of LINC01266 in various types of cancer makes it a promising candidate for use as a diagnostic marker. Additionally, since LINC01266 has been shown to play a role in cell survival, it is also a potential biomarker for cancer progression.

Conclusion

In conclusion, LINC01266 is a potential drug target and biomarker that has been shown to be involved in various diseases, including cancer. The high expression of LINC01266 in these diseases makes it a promising candidate for small molecules and other therapeutic agents. Additionally, LINC01266 has also been shown to be a potential biomarker for cancer, which could make it an attractive target for diagnostic tools. Further research is needed to fully understand the role of LINC01266 in disease and to develop effective therapeutic agents.

Protein Name: Long Intergenic Non-protein Coding RNA 1266

The "LINC01266 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01266 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets